Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
Bill Gates to give away most of his $200 billion fortune through the Gates Foundation, with a focus on improving health, education, and development in Africa.
Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
Bill Gates to give away most of his $200 billion fortune through the Gates Foundation, with a focus on improving health, education, and development in Africa.